[Refractory infection with Pseudomonas aeruginosa and the trend of clinical studies].
Tanimoto
H
H
Department of Internal Medicine IV, Tokyo Jikei University School of Medicine.
D000328:Adult; D001425:Bacterial Outer Membrane Proteins / Q000378:metabolism; D001988:Bronchiolitis / Q000188:drug therapy / Q000382:microbiology*; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000382:microbiology*; D004917:Erythromycin / Q000008:administration & dosage; D005098:Exotoxins / Q000378:metabolism; D006801:Humans; D008297:Male; D010196:Pancreatic Elastase / Q000378:metabolism; D011552:Pseudomonas Infections; D011550:Pseudomonas aeruginosa / Q000378:metabolism; D012697:Serine Endopeptidases / Q000378:metabolism
D001425:Bacterial Outer Membrane Proteins; D005098:Exotoxins; D004917:Erythromycin; D012697:Serine Endopeptidases; D010196:Pancreatic Elastase; C032923:microbial serine proteinases